New immunotherapies for sepsis.
Young
L S
LS
Kuzell Institute, San Francisco, CA, USA.
Wenzel
R P
RP
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016905:Gram-Negative Bacterial Infections / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D053590:Interleukin 1 Receptor Antagonist Protein; D012795:Sialoglycoproteins / Q000627:therapeutic use*; D018746:Systemic Inflammatory Response Syndrome / Q000628:therapy*
D000911:Antibodies, Monoclonal; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D012795:Sialoglycoproteins